Lab Test Services Provider
Lab Testing Franchise in a Southwest U.S. Metropolitan Area
On NextCompany since September 30, 2026 (15 days)
Location undisclosed
Business overview
This lab testing franchise operates eight locations in a Southwest U.S. metropolitan area. It serves consumers and businesses with wellness panels, nutritional and sexual health screenings, DNA testing, and drug testing. The franchise holds exclusive rights across four key counties. A cloud-based platform supports standardized processes and centralized oversight.
The business reports $4,406,342 in gross revenue and $881,165 in EBITDA. Its national employer drug and alcohol testing program launched in 2025. Eight leased facilities range from 890 to 1,542 square feet. The owners seek an eventual full exit and welcome negotiated transition terms and varied deal structures.
Who is a good fit for this business
- Healthcare operators seeking a franchise with exclusive rights across four key counties.
- Laboratory testing companies seeking eight metropolitan locations and an employer drug and alcohol testing program.
- Buyers planning growth through telemedicine alliances or expanded wellness diagnostics.
Details
- Reason for selling
- Owners seek an eventual full exit and are open to a negotiable transition period and a variety of deal structures.
- Real estate
- Leased
Frequently Asked Questions
The franchise serves consumers and businesses across eight locations in a Southwest U.S. metropolitan area. It offers wellness panels, nutritional and sexual health screenings, DNA and paternity testing, and drug testing.
The business reports $4,406,342 in gross revenue and $881,165 in EBITDA. Benchmark International markets the lab testing franchise.
The franchise holds exclusive rights across four key counties. Its eight leased facilities measure 890 to 1,542 square feet, and their leases permit assumption after a sale.
The owners seek an eventual full exit. They remain open to a negotiable transition period and a variety of deal structures.
The business identifies telemedicine alliances and expanded wellness diagnostics as growth opportunities. It launched a national employer drug and alcohol testing program in 2025.